Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
𝛼
SK
or Search
SIGN UP
SIGN IN
ENTITY
Yungjin Pharmaceutical Co (003520 KS)
Watchlist
21
Analysis
Health Care
•
South Korea
Yungjin Pharmaceutical Co., Ltd. manufactures pharmaceutical and medical drugs, such as nutritional drinks, antibiotics, and intravenous fluids.
more
Watchlist
All
Insights
Primers
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Hana Tour Service
•
26 Apr 2022 14:33
KOSPI 200 June Rebalancing: Nearly Finalized Results with 7 Adds/Deletes
KOSPI 200 June rebalancing results are nearly finalized with seven additions and seven deletions. There have been several changes of late.
Sanghyun Park
Follow
617 Views
Share
bullish
•
Hana Tour Service
•
10 Mar 2022 12:37
KOSPI 200 Rebalancing Screening: Few Noticeable Changes in the Race
This post offers the latest update on the KOSPI 200 rebalancing screening. There are a few noticeable changes: Hana Tour (addition) and Bukwang...
Sanghyun Park
Follow
520 Views
Share
bullish
•
LG Energy Solution
•
04 Feb 2022 05:29
KOSPI 200 Rebalancing Screening: Prediction Likelihood, Special Issues, & Passive Impacts
This post has the screening results of the KOSPI 200 rebalancing, with a focus on prediction likelihood, special considerations, and passive impacts.
Sanghyun Park
Follow
516 Views
Share
bullish
•
Meritz Securities
•
16 May 2021 16:36
Earnings Surprise KOSPI Stocks Potentially Hedging Against Inflation for Basket & Pairs Trades
This post finds the first-quarter earnings surprise stocks in KOSPI that potentially hedge against inflation for basket and pairs trades.
Sanghyun Park
Follow
391 Views
Share
bullish
•
KT&G Corporation
•
10 May 2018 11:57
KT&G (033780 KS): A Li’l Smoking Device to Drive Growth
Low core profit valuation, strong cash levels, and earnings on an upcycle trend relative to its sector National roll out of heat-non-burn (HNB)...
A. Stotz Investment Research
Follow
319 Views
Share
First
Previous
1
2
3
4
5
Next
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
How Smartkarma Compares
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.5
x